Dr. Dirk Arnold on Sirflox and its Effect on Liver Metastases Targeted Oncology 1:09 8 years ago 218 Скачать Далее
Dr. Dick Arnold on Sirflox and its Effect on Liver Metastases Targeted Oncology 1:09 8 years ago 52 Скачать Далее
Dr. Dirk Arnold on Sirflox Study Results in Colorectal Cancer OncLive 1:46 9 years ago 416 Скачать Далее
Dr. Dirk Arnold on Second-Line Bevacizumab Continuation Therapy for Metastatic Colorectal Cancer OncLive 1:15 12 years ago 773 Скачать Далее
Dr. Arnold on a Phase III Trial Examining Options for Maintenance Therapy in mCRC OncLive 2:45 10 years ago 374 Скачать Далее
Unmet needs and future directions in the treating rare pancreatic cancers VJOncology 1:45 1 year ago 33 Скачать Далее
Arnold Metastatic colorectal cancer, providing the continuum of care ESMO 2016 OncoInfoTV 3:47 7 years ago 238 Скачать Далее
Findings of the SIRFLOX Study in Metastatic Colorectal Cancer Targeted Oncology 0:55 7 years ago 63 Скачать Далее
Advantages of Using Y-90 for the First-Line Treatment of Patients With Liver Metastases from mCRC Targeted Oncology 1:59 8 years ago 1 388 Скачать Далее
What’s in the pipeline? GI-Cancer: Dirk Arnold, Freiburg Oncoletter 5:36 9 years ago 603 Скачать Далее
Arnold The impact of new ESMO colorectal cancer consensus guidelines ESMO 2016 OncoInfoTV 2:07 7 years ago 438 Скачать Далее
Dr. Kennedy on Importance of SIRFLOX Study in Liver-Metastatic CRC OncLive 1:19 7 years ago 153 Скачать Далее
The advantages of establishing national and international GI registries VJOncology 0:58 1 year ago 41 Скачать Далее
